Vident Investment Advisory, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Vident Investment Advisory, LLC

$0
Q3 2023

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$700.03 - $830.35 $3.26 Million - $3.86 Million	-4,650 Reduced 22.92%	15,634 $11.2 Million
Q1 2023 May 15, 2023	BUY	$680.49 - $826.97 $1.14 Million - $1.39 Million	1,679 Added 9.02%	20,284 $16.7 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $6.89 Million - $7.48 Million	9,755 Added 110.23%	18,605 $13.4 Million
Q3 2022 Nov 14, 2022	SELL	$573.97 - $724.32 $5.68 Million - $7.17 Million	-9,897 Reduced 52.79%	8,850 $5.79 Million
Q2 2022 Aug 15, 2022	BUY	$548.35 - $738.84 $5.36 Million - $7.22 Million	9,768 Added 108.79%	18,747 $11.1 Million
Q1 2022 May 16, 2022	SELL	$595.12 - $698.43 $2.76 Million - $3.24 Million	-4,634 Reduced 34.04%	8,979 $6.27 Million
Q4 2021 Feb 14, 2022	SELL	$543.48 - $670.97 $1.28 Million - $1.58 Million	-2,355 Reduced 14.75%	13,613 $8.6 Million
Q3 2021 Nov 12, 2021	BUY	$574.03 - $680.96 $1.78 Million - $2.11 Million	3,100 Added 24.09%	15,968 $9.66 Million
Q2 2021 Aug 13, 2021	SELL	$472.8 - $558.54 $775,392 - $916,005	-1,640 Reduced 11.3%	12,868 $7.19 Million
Q1 2021 May 14, 2021	BUY	$446.73 - $548.2 $2.16 Million - $2.65 Million	4,834 Added 49.97%	14,508 $6.86 Million
Q4 2020 Feb 08, 2021	BUY	$478.3 - $607.98 $678,707 - $862,723	1,419 Added 17.19%	9,674 $4.67 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $268,561 - $324,497	493 Added 6.35%	8,255 $4.62 Million
Q2 2020 Jul 17, 2020	BUY	$493.32 - $643.92 $4,933 - $6,439	10 Added 0.13%	7,762 $4.84 Million
Q1 2020 May 12, 2020	BUY	$336.18 - $494.43 $1.1 Million - $1.62 Million	3,276 Added 73.19%	7,752 $3.79 Million
Q4 2019 Feb 11, 2020	SELL	$274.13 - $376.51 $121,439 - $166,793	-443 Reduced 9.01%	4,476 $1.68 Million
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $46,214 - $53,807	-169 Reduced 3.32%	4,919 $1.36 Million
Q2 2019 Aug 12, 2019	BUY	$299.6 - $414.82 $196,238 - $271,707	655 Added 14.78%	5,088 $1.59 Million
Q1 2019 May 08, 2019	SELL	$372.08 - $439.57 $32,743 - $38,682	-88 Reduced 1.95%	4,433 $1.82 Million
Q4 2018 Feb 14, 2019	BUY	$335.82 - $403.04 $1.08 Million - $1.29 Million	3,209 Added 244.59%	4,521 $1.69 Million
Q3 2018 Nov 14, 2018	SELL	$351.14 - $408.51 $141,158 - $164,221	-402 Reduced 23.45%	1,312 $530,000
Q2 2018 Aug 14, 2018	SELL	$284.6 - $344.99 $79,403 - $96,252	-279 Reduced 14.0%	1,714 $591,000
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $55,268 - $68,911	-175 Reduced 8.07%	1,993 $637,000
Q4 2017 Feb 15, 2018	BUY	$358.63 - $469.95 $616,843 - $808,314	1,720 Added 383.93%	2,168 $815,000
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $193,258 - $225,792	448	448 $200,000

Others Institutions Holding REGN

# of Institutions

1,534

Shares Held

83.6M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $75.2B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.

Account